Biotech Co. Gets OK For $16M Sale Of Monkey Cell Royalties
By Ben Zigterman · February 9, 2026, 6:03 PM EST
Biotechnology company Alachua Government Services received approval on Monday from a Delaware bankruptcy judge for a $16 million sale to healthcare investment firm OrbiMed Advisors LLC of the royalty rights to a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login